Log In
BCIQ
Print this Print this
 

Epicyn (Microcyn Scar Management Hydrogel)

  Manage Alerts
Collapse Summary General Information
Company Sonoma Pharmaceuticals Inc.
DescriptionHydrogel containing oxychlorine compounds
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationScars / wrinkles
Indication DetailsTo manage old and new hypertrophic and keloid scarring
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5.1M

$5.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/20/2012

$5.1M

$5.1M

0

Get a free BioCentury trial today